Stay updated on Nivolumab and Axitinib in RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Axitinib in RCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:19:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:19:06.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now presents a 403 Forbidden error page, replacing the study record content. The site header and footer remain visible.
    Difference
    20%
    Check dated 2026-09-20T20:29:31.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.6.6' appears, replacing the previous 'Revision: v3.6.5'. This indicates an internal update to the page version and does not alter the visible content.
    Difference
    0.1%
    Check dated 2026-08-30T08:24:50.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.6.5, was added replacing the previous Revision: v3.6.4. This indicates a small update to the page's revision history without altering displayed information.
    Difference
    0.1%
    Check dated 2026-08-08T23:31:49.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.4, replacing the previous v3.6.3 tag. This indicates a minor update to the page's revision metadata rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T13:12:21.000Z thumbnail image

Stay in the know with updates to Nivolumab and Axitinib in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.